|

Allogeneic Adipose-derived Mesenchymal Stem Cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Allogeneic Adipose-derived MSCs, Allogeneic Adipose-derived Stem/Stromal Cells, Allogeneic Mesenchymal Stem/Stromal Cells

Pipeline

Phase 1: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Recurrent Astrocytoma, IDH-Mutant, Grade 41
  • Recurrent Glioblastoma, IDH-Wildtype1
  • Astrocytoma, Grade IV1
  • Cancer1

Jacksonville, Florida1 trial

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Mayo Clinic in Florida

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.